Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Olanzapine vs Quetiapine for Mania in Children and Adolescents With Bipolar Disorder
NCT00182013Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2001
- Primary completion
- Feb 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of risperidone, olanzapine and quetiapine in bipolar disorder (BD) (3 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Young Mania Rating Scale at 8 weeks. Started Jun 2001; status: completed.
02
Drugs
risperidoneolanzapinequetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00182013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182013.